经颈动脉血运重建(TCAR)在80岁及以上患者中的结局
所有病例技术成功,30天内无同侧脑血管缺血事件、心肌梗死、颅神经损伤或死亡;≥80岁组手术时间、阻断/血流逆转时间、透视时间与<80岁组无显著差异,但住院时间显著更长(中位2.0±1.0天 vs 1.0±0.0天,P=<0.001)。
要点
- TCAR在≥80岁症状性或无症状高危颈动脉狭窄患者中技术成功率高,围术期无脑缺血事件、心梗或死亡。
- ≥80岁患者手术时间、阻断/血流逆转时间、透视时间与<80岁患者无显著差异。
- ≥80岁患者住院时间显著长于<80岁患者(中位2.0±1.0天 vs 1.0±0.0天,P=<0.001)。
核心结论
- TCAR可在症状性和无症状高危老年患者中成功实施,本系列未发现围术期脑缺血事件、心肌梗死或死亡。
主要发现
- 所有病例技术成功,30天内无同侧脑血管缺血事件(卒中或短暂性脑缺血发作)、心肌梗死、颅神经损伤或死亡。
- ≥80岁患者平均手术时间47±12分钟,阻断/血流逆转时间4.7±1.1分钟,透视时间4.1±1.6分钟,中位住院时间2.0±1.0天。
- 手术时间、阻断/血流逆转时间和透视时间在年龄组间无显著差异,但住院时间有显著差异,<80岁患者中位住院时间1.0±0.0天(P=<0.001)。
临床怎么用
- 对于≥80岁的高危颈动脉狭窄患者,TCAR是一种可行的血运重建选择,围术期脑血管并发症风险低。
- 术后应关注≥80岁患者住院时间可能延长,做好相应资源配置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid revascularization, both endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS), are associated with an increased risk of adverse outcomes in patients aged ≥80 years. Transcarotid artery revascularization (TCAR) is a technique that combines surgical principles of neuroprotection with less invasive endovascular techniques to treat severe carotid stenosis. Data from a recent registry study comparing TCAR with that of CEA and TFCAS demonstrated no significant difference in outcomes between TCAR and CEA in patients aged ≥80 years, and a significant reduction in stroke and composite outcomes between TCAR and TFCAS in patients aged ≥80 years. To add to these studies, a more in-depth analysis of demographic, procedural, and outcome factors is warranted for elderly patients aged ≥80 years undergoing TCAR. At our center, with a large volume of elderly patients based on local demographics, we expect there will be no significant effect of age on outcome measures between patients aged <80 years and those aged ≥80 years. METHODS: Data were collected retrospectively for patients undergoing TCAR for symptomatic (≥50%) or asymptomatic (≥80%) extracranial carotid artery stenosis. Primary endpoints were the incidence of ipsilateral cerebrovascular ischemic event (stroke or transient ischemic attack), myocardial infarction (MI), cranial nerve injury, and death through 30 days after the procedure. Secondary endpoints were postoperative length of hospital stay (LOS), procedure time, carotid artery clamp/flow reversal time, and fluoroscopy time. Subgroup analyses were performed to examine the effect of inpatient/outpatient status, carotid symptomatology, and type of anesthesia on secondary outcomes. RESULTS: Ninety-seven TCAR procedures were performed at our institution during the study period, of which 43 (44%) were on patients aged ≥80 years. Technical success was achieved in all cases, with no incidence of cerebrovascular ischemic event, MI, cranial nerve injury, or mortality through 30 days after procedure. In patients aged ≥80 years, the mean procedure time was 47 ± 12 min, clamp/flow reversal time was 4.7 ± 1.1 min, fluoroscopy time was 4.1 ± 1.6 min, and median LOS was 2.0 ± 1.0 days. Procedure time, clamp/flow reversal time, and fluoroscopy time were not significantly different between the age groups. However, there was a significant difference in the LOS, with patients aged <80 years demonstrating a median LOS of 1.0 ± 0.0 days (P = <0.001). CONCLUSIONS: Our experience with TCAR confirms that it can be performed successfully in both symptomatic and asymptomatic high-risk elderly patients, with our series finding no incidence of perioperative cerebral ischemic event, MI, or death.
引用
- Ghamraoui AK, Ricotta JJ. Outcomes of Transcarotid Artery Revascularization (TCAR) in Octogenarians and Older. Ann Vasc Surg. 2020. PMID: 32479873. doi:10.1016/j.avsg.2020.05.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。